Covid 19 vaccine

Phase II trial to commence on August 6, 2020

As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on…

The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500…

The list of 92 AMC-eligible economies includes all economies with GNI per capita under $4,000 plus other World Bank International…

SII had submitted a revised proposal on Wednesday after the expert panel had asked it to revise its protocol for the trials…

The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October…

It will test its vaccine candidate in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and…

Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups;…

The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…

The study is expected to include about 120 sites globally and up to 30,000 participants